Hearing deterioration in patients with a non-growing vestibular schwannoma

Acta Oto-Laryngologica

Volumn 123, Issue 1, 2003, Pages 51-54

  Graamans, Kees ^a   Van Dijk, Johannes E ^b   Janssen, Luuc W ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acoustic neuroma; Conservative management; Pure tone audiometry; Speech audiometry

Indexed keywords

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HEARING DISORDER; HUMAN; MALE; NEURILEMOMA; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SPEECH AUDIOMETRY; SPEECH DISCRIMINATION; TUMOR GROWTH; VESTIBULAR DISORDER;

ADULT; AGED; AGED, 80 AND OVER; AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; AUDITORY THRESHOLD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMA, ACOUSTIC; SPEECH RECEPTION THRESHOLD TEST;

EID: 0037275162     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036554021000028075     Document Type: Article

References (19)

1. Deen HG, Ebersold MJ, Harner SG, et al. Conservative management of acoustic neuroma: an outcome study. Neurosurgery 1996; 39: 260-4.
2. Selesnick SH, Johnson G. Radiologic surveillance of acoustic neuromas. Am J Otol 1998; 19: 846-9.
3. Mirz F, Pedersen CB, Fiirgaard B, Lundorf E. Incidence and growth pattern of vestibular schwannomas in a Danish county, 1977-98. Acta Otolaryngol Suppl (Stockh) 2000; 543: 30-3.
4. O'Reilly B, Murray CD, Hadley DM. The conservative management of acoustic neuroma: a review of forty-four patients with magnetic resonance imaging. Clin Otolaryngol 2000; 25: 82-6.
5. Shin YJ, Fraysse B, Cognard C, et al. Effectiveness of conservative management of acoustic neuromas. Am J Otol 2000; 21: 857-62.
6. Hoistad DL, Melnik G, Mamakoglu B, Battista R, O'Connor CA, Wiet RJ. Update on conservative management of acoustic neuroma. Otol Neurotol 2001; 22: 682-5.
7. Bosman AJ, Smoorenburg GF. Woordenlijst voor spraakaudiometrie. Rotterdam, the Netherlands: Nederlandse Vereniging voor Audiologie, 1992.
8. Jerger J, Jerger S. Diagnostic significance of PB word functions. Arch Otolaryngol 1971; 93: 573-80.
9. Van Dijk JE, Duijndam J, Graamans K. Acoustic neuroma: deterioration of speech discrimination related to thresholds in pure-tone audiometry. Acta Otolaryngol (Stockh) 2000; 120: 627-32.
10. Van Leeuwen JPPM, Cremers CWRJ, Thewissen NPMW. Acoustic neuroma: correlation among tumor size, symptoms, and patient age. Laryngoscope 1995; 105: 701-7.
11. Tierney PA, Chitnavis BP, Sheriff M, Strong AJ, Gleeson MJ. The relationship between pure tone thresholds and the radiological dimensions of acoustic neuromas. Skull Base Surg 1998; 8: 149-51.
12. Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope 2000; 110: 497-508.
13. Sakamato T, Fukuda S, Inuyama Y. Hearing loss and growth rate of acoustic neuromas in follow-up observation policy. Auris Nasus Larynx 2001; Suppl 28: 23-7.
14. Tschudi DC, Linder TE, Fisch U. Conservative management of unilateral acoustic neuromas. Am J Otol 2000; 21: 722-8.
15. Massick DD, Welling DB, Dodson EE, et al. Tumor growth and audiometric change in vestibular schwannomas managed conservatively. Laryngoscope 2000; 110: 1843-9.
16. Warrick P, Bance ML, Rutka JA. The risk of hearing loss in nongrowing, conservatively managed acoustic neuromas. Am J Otol 1999; 20: 758-62.
17. Walsh RM, Bath AP, Bance ML, Keller A, Rutka JA. Consequences to hearing during the conservative management of vestibular schwannomas. Laryngoscope 2000; 110: 250-5.
18. Dirks DD, Kamm C, Bower D, Betsworth A. Use of performance intensity functions for diagnosis. J Speech Hear Disord 1977; 42: 408-15.
19. Schuknecht HF. Pathology of the ear. Philadelphia, PA: Lea & Febiger, 1993: 466-8.